A股異動丨白酒板塊回升 捨得酒業升超7% 貴州茅台績後升2%
A股白酒股拉昇回暖,其中,捨得酒業升超7%,貴州茅台績後升2%,酒鬼酒、水井坊、山西汾酒、古井貢酒等跟升。華泰證券研報表示,2025年春糖白酒產業端反饋平穩,基本面逐步恢復,節後需求環比改善。白酒進入良性修復期,看好短期基本面表現突出,長期具備業績韌性/有望穿越週期的頭部酒企。個股方面,貴州茅台2024年公司實現營業總收入1741.44億元,同比增長15.66%;歸屬於上市公司股東的淨利潤862.28億元,同比增長15.38%。基本每股收益68.64元。每10股擬派發現金紅利276.24元(含税)。另外,Q4淨利254.01億元,環比增長32.77%。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.